This publication summarises an independent presentation on immune thrombocytopenia (ITP) given at the Haematology Society of Australia and New Zealand (HSANZ) Annual Branch Meeting in Christchurch in April 2025. Dr Danny Hsu from Sydney, Australia, spoke about the evolution of ITP guidelines, current trends in ITP management, specific insights into ITP therapy, and emerging new ITP therapies. This resource was created with funding from Novartis.
Please login below to download this issue (PDF)